Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2016

01-07-2016 | Clinical Practice: Clinical Images

Diffuse Alveolar Hemorrhage: Blood, Sweat and Tears

Authors: Kreshnik Zejnullahu, M.D., Shabnam Khatami, M.D., Reza Sedighi Manesh, M.D.

Published in: Journal of General Internal Medicine | Issue 7/2016

Login to get access

Excerpt

A 68-year-old woman with systemic sclerosis and interstitial lung disease presented with progressive cough and dyspnea. She was in respiratory distress, with a heart rate of 110 beats per minute, respiratory rate 35, and oxygen saturation 63 % on ambient air, which improved to 94 % with 15 l of 100 % oxygen by face mask. Lungs had diffuse crackles throughout. Lab results revealed hemoglobin of 7.2 g/dL. Her chest x-ray showed multifocal bilateral airspace opacities (Fig. 1). She was intubated; subsequent bronchoscopy revealed progressively hemorrhagic lavage fluid (Fig. 2) indicative of diffuse alveolar hemorrhage (DAH). She was started on high-dose intravenous corticosteroid and cyclophosphamide. Due to ongoing DAH, bleeding was temporized with intravenous aminocaproic acid and intrabronchial activated factor VIIa (rFVIIa).13 Ultimately, she developed ventilator-associated pneumonia and died.
Literature
1.
go back to reference Rathi NK, Tanner AR, Dinh A, et al. Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage. Bone Marrow Transplant. 2015;50:420–6.CrossRefPubMed Rathi NK, Tanner AR, Dinh A, et al. Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage. Bone Marrow Transplant. 2015;50:420–6.CrossRefPubMed
2.
go back to reference Pathak V, Kuhn J, Gabriel D, Barrow J, Jennette JC, Henke DC. Use of activated factor VII in patients with diffuse alveolar hemorrhage: a 10 years institutional experience. Lung. 2015;193:375–9.CrossRefPubMed Pathak V, Kuhn J, Gabriel D, Barrow J, Jennette JC, Henke DC. Use of activated factor VII in patients with diffuse alveolar hemorrhage: a 10 years institutional experience. Lung. 2015;193:375–9.CrossRefPubMed
3.
go back to reference Heslet L, Nielsen JD, Nepper-Christensen S. Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH)—a review of a new treatment paradigm. Biologics. 2012;6:37–46.PubMedPubMedCentral Heslet L, Nielsen JD, Nepper-Christensen S. Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH)—a review of a new treatment paradigm. Biologics. 2012;6:37–46.PubMedPubMedCentral
4.
go back to reference Lichtenberger JP, Digumarthy SR, Abbott GF, Shepard J-AO, Sharma A. Diffuse pulmonary hemorrhage: clues to the diagnosis. Curr Probl Diagn Radiol. 2014;43:128–39.CrossRefPubMed Lichtenberger JP, Digumarthy SR, Abbott GF, Shepard J-AO, Sharma A. Diffuse pulmonary hemorrhage: clues to the diagnosis. Curr Probl Diagn Radiol. 2014;43:128–39.CrossRefPubMed
5.
go back to reference Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997;76:192–202.CrossRef Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997;76:192–202.CrossRef
6.
go back to reference Ioachimescu OC, Stoller JK. Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleve Clin J Med. 2008;75:258. 260, 264–265 passim.CrossRefPubMed Ioachimescu OC, Stoller JK. Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleve Clin J Med. 2008;75:258. 260, 264–265 passim.CrossRefPubMed
7.
go back to reference Phillips D, Phillips B, Mannino D. A case study and national database report of progressive systemic sclerosis and associated conditions. J Women’s Health. 1998;7:1099–104.CrossRef Phillips D, Phillips B, Mannino D. A case study and national database report of progressive systemic sclerosis and associated conditions. J Women’s Health. 1998;7:1099–104.CrossRef
Metadata
Title
Diffuse Alveolar Hemorrhage: Blood, Sweat and Tears
Authors
Kreshnik Zejnullahu, M.D.
Shabnam Khatami, M.D.
Reza Sedighi Manesh, M.D.
Publication date
01-07-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 7/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3593-6

Other articles of this Issue 7/2016

Journal of General Internal Medicine 7/2016 Go to the issue

Healing Arts: Text and Context

The Question that I Could Not Answer

Letter to the Editor

Response to Dr. Westfall

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.